| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |